Skip to content
Jazz Pharmaceuticals plc (JAZZ) Stock Price, Key Stats & Insider Trading
Home / Companies / JAZZ JAZ
Jazz Pharmaceuticals plc (JAZZ) XNAS PHARMACEUTICAL PREPARATIONS Net insider selling (90d)
Latest JAZZ Insider Trades
About Jazz Pharmaceuticals plc (JAZZ) Jazz Pharmaceuticals is an Ireland-domiciled biopharmaceutical firm focused primarily on treatments for sleeping disorders and oncology. Jazz has nine approved drugs across neuroscience and oncology indications; its portfolio includes Xyrem and Xywav for narcolepsy, Zepzelca for the treatment of metastatic small cell lung cancer, Rylaze for acute lymphoblastic leukemia, and Vyxeos for acute myeloid leukemia. In May 2021, Jazz acquired GW Pharmaceuticals and gained its leading product, Epidiolex for the treatment of severe, rare forms of epilepsy.
Headquarters DUBLIN
Employees 2,890
Listed 2007
Exchange XNAS https://www.jazzpharmaceuticals.com SEC filings for JAZZ on EDGAR
90-Day SEC Filing Activity Form 4 transaction type Transactions Shares Total value Open-market sale 7 28,456 $6.82M Grant or award 11 17,655 Option exercise 4 20,644
JAZZ Insider Transactions (Form 4) 51 90 Form 4 filings on record, the earliest from Nov 5, 2024, newest first. Filing history page 3 of 3.
Date Insider Transaction Security Shares Price Value Nov 18, 2025 PC Patricia Carr - Officer Option exercise Ordinary Shares 5,250
Recent JAZZ Form 8-K Filings 5
Recent JAZZ Form 144 Notices of Proposed Sale 3 A Form 144 is notice of an INTENDED sale, not a completed one. It often precedes the Form 4 that reports the trade actually happening.
Filed Filer Relationship Shares Market value Notice Aug 27, 2026 ROBERT IANNONE Officer 76,921 $19.21M View on EDGAR Aug 7, 2026 ORiordan Anne Director
JAZZ Insider Trading - FAQ
What is the latest insider trade for JAZZ? Jazz Pharmaceuticals plc (JAZZ) had 26 insider filings in the last 90 days, with the most recent on 2026-08-07. The full record for JAZZ runs to 90 Form 4 filings, the earliest from 2024-11-05. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
How many insiders are buying JAZZ stock? No insider purchases of JAZZ were filed in the last 90 days. 4 purchases are on record for this company.
How many insiders are selling JAZZ stock? 7 insider sales of JAZZ were filed in the last 90 days, totaling $6.82M.
Where can I see JAZZ SEC filings (Form 4, 10-K, 10-Q, 8-K)? This page tracks JAZZ Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
How can I follow JAZZ insider buys? Create a free InsiderAlpha account and press Watch on this page to add JAZZ to your watchlist. A free account also opens the full scored daily plan with every past day and 3 months of price history. No card is required. Sign up at https://insideralpha.ai/register.
More Health Care Companies with Insider Activity Every Form 4 below links to the original document on SEC EDGAR, so the numbers on this page can be checked against the filing they came from.
Related Companies - Recent Insider Activity What is SEC Form 4? The filing insiders must submit within two business days of a trade, and how to read its transaction codes. Track JAZZ insider activity as it files Real-time Form 4 alerts, AI-scored daily trade ideas and 10b5-1 plan flags.
Sign up free Jul 1, 2026
Market cap $15.87B
P/E ratio 28.30
Dividend yield -
Average volume 926.4K
52 week high $266.38
52 week low $123.88
Today's high $250.64
Today's low $244.49
Open $249.48
Volume 1.21M
Previous close $251.10
Shares outstanding 64.91M Market cap
$15.87B
2,890 employees
JAZZ Insider Sentiment - Last 90 Days Share of open-market insider dollar volume that was buying versus selling, from SEC Form 4 filings.
0% Buying 100% Selling
0 insider purchases totaling $0 against 7 sales totaling $6.82M.
Most-Active JAZZ Insiders - Last 90 Days 10 Tax withholding / forfeiture 6 17,927
Dollar totals are shown for open-market purchases and sales only. Grants, option exercises, gifts and tax withholding are reported by share count because they are not trades at a market price.
Nov 18, 2025 PC Patricia Carr - Officer Open-market sale Ordinary Shares 5,250 $182.07 $956K
Nov 18, 2025 PC Patricia Carr - Officer Open-market sale Ordinary Shares 69 $181.66 $13K
Nov 18, 2025 PC Patricia Carr - Officer Option exercise Non-Qualified Stock Option (right to buy) 5,250 $0.00 -
Nov 18, 2025 RW Rick E. Winningham - Director Open-market sale Ordinary Shares 5,500 $180.86 $995K
Nov 17, 2025 RI Robert Iannone - Officer Open-market sale Ordinary Shares 7,159 $168.26 $1.20M
Oct 1, 2025 BC Bruce C. Cozadd - Director Open-market sale Ordinary Shares 2,000 $131.78 $264K
Oct 3, 2025 BC Bruce C. Cozadd - Director Open-market sale Ordinary Shares 3,500 $140.00 $490K
Sep 14, 2025 BC Bruce C. Cozadd - Director Tax withholding / forfeiture Ordinary Shares 15,647 $126.16 $1.97M
Sep 2, 2025 BC Bruce C. Cozadd - Director Open-market sale Ordinary Shares 3,000 $127.23 $382K
Sep 2, 2025 BC Bruce C. Cozadd - Director Open-market sale Ordinary Shares 3,000 $130.00 $390K
Aug 8, 2025 NR Norbert G. Riedel - Director Tax withholding / forfeiture Ordinary Shares 1,805 $111.25 $201K
Aug 7, 2025 PK Patrick Kennedy - Director Grant or award Ordinary Shares 3,507 $0.00 -
Aug 8, 2025 PK Patrick Kennedy - Director Tax withholding / forfeiture Ordinary Shares 1,959 $111.25 $218K
Aug 7, 2025 JC Jennifer E. Cook - Director Grant or award Ordinary Shares 3,507 $0.00 -
Aug 8, 2025 JC Jennifer E. Cook - Director Tax withholding / forfeiture Ordinary Shares 1,805 $111.25 $201K
Aug 8, 2025 RW Rick E. Winningham - Director Tax withholding / forfeiture Ordinary Shares 1,805 $111.25 $201K
Aug 8, 2025 HM Heather Ann McSharry - Director Tax withholding / forfeiture Ordinary Shares 1,959 $111.25 $218K
Aug 7, 2025 AO Anne Oriordan - Director Grant or award Ordinary Shares 3,507 $0.00 -
Aug 8, 2025 AO Anne Oriordan - Director Tax withholding / forfeiture Ordinary Shares 1,805 $111.25 $201K
Aug 8, 2025 PE Patrick G. Enright - Director Tax withholding / forfeiture Ordinary Shares 1,805 $111.25 $201K
Aug 7, 2025 SM Seamus Mulligan - Director Grant or award Ordinary Shares 3,507 $0.00 -
Aug 8, 2025 MS Mark Douglas Smith - Director Tax withholding / forfeiture Ordinary Shares 1,805 $111.25 $201K
Aug 8, 2025 KO Kenneth W. O'Keefe - Director Tax withholding / forfeiture Ordinary Shares 1,805 $111.25 $201K
Aug 7, 2025 RG Renee D. Gala - Officer Grant or award Ordinary Shares 18,808 $0.00 -
Aug 7, 2025 LH Laura Hamill - Director Grant or award Ordinary Shares 3,507 $0.00 -
Aug 8, 2025 LH Laura Hamill - Director Tax withholding / forfeiture Ordinary Shares 1,805 $111.25 $201K
Aug 5, 2025 SP Samantha Pearce - Officer Tax withholding / forfeiture Ordinary Shares 577 $116.10 $67K
Aug 1, 2025 BC Bruce C. Cozadd - Officer Open-market sale Ordinary Shares 1,000 $113.21 $113K
Jul 1, 2025 BC Bruce C. Cozadd - Officer Open-market sale Ordinary Shares 500 $105.26 $53K
Jul 1, 2025 BC Bruce C. Cozadd - Officer Open-market sale Ordinary Shares 500 $110.00 $55K
Jun 2, 2025 BC Bruce C. Cozadd - Officer Open-market sale Ordinary Shares 500 $107.90 $54K
Jun 3, 2025 BC Bruce C. Cozadd - Officer Open-market sale Ordinary Shares 500 $110.00 $55K
May 9, 2025 SM Seamus Mulligan - Director Open-market purchase Ordinary Shares 80,684 $98.10 $7.92M
May 9, 2025 SM Seamus Mulligan - Director Open-market purchase Ordinary Shares 19,216 $98.91 $1.90M
May 9, 2025 SM Seamus Mulligan - Director Open-market purchase Ordinary Shares 100 $99.71 $10K
May 12, 2025 SM Seamus Mulligan - Director Open-market purchase Ordinary Shares 1,621 $103.00 $167K
May 1, 2025 BC Bruce C. Cozadd - Officer Open-market sale Ordinary Shares 1,000 $116.35 $116K
May 2, 2025 BC Bruce C. Cozadd - Officer Open-market sale Ordinary Shares 500 $120.00 $60K
Apr 1, 2025 BC Bruce C. Cozadd - Officer Open-market sale Ordinary Shares 1,500 $123.75 $186K
Dec 5, 2024 RG Renee D. Gala - Officer Tax withholding / forfeiture Ordinary Shares 80 $123.45 $10K
Dec 2, 2024 PC Patricia Carr - Officer Open-market sale Ordinary Shares 53 $122.49 $6K
Dec 2, 2024 BC Bruce C. Cozadd - Officer Open-market sale Ordinary Shares 2,000 $121.17 $242K
Nov 8, 2024 NP Neena M. Patil - Officer Open-market sale Ordinary Shares 3,700 $123.41 $457K
Nov 1, 2024 BC Bruce C. Cozadd - Officer Open-market sale Ordinary Shares 1,000 $110.84 $111K
$ELAN
Elanco Animal Health Inc
Bruce C. Cozadd - DirectorOpen-market sale$1.52M
